U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C21H27NO
Molecular Weight 309.4452
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BENPROPERINE

SMILES

CC(COC1=CC=CC=C1CC2=CC=CC=C2)N3CCCCC3

InChI

InChIKey=JTUQXGZRVLWBCR-UHFFFAOYSA-N
InChI=1S/C21H27NO/c1-18(22-14-8-3-9-15-22)17-23-21-13-7-6-12-20(21)16-19-10-4-2-5-11-19/h2,4-7,10-13,18H,3,8-9,14-17H2,1H3

HIDE SMILES / InChI

Molecular Formula C21H27NO
Molecular Weight 309.4452
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/16297353 and http://www.ncbi.nlm.nih.gov/pubmed/5301345

Benproperine (Cofrel) is a cough suppressant. It is used for symptomatic relief of cough. Cofrel is 2-4 times as potent as codeine in suppressing cough in animals. It acts peripherally by blocking afferent sensory nerve impulses originating from receptors in the lungs and pleura.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
Cofrel

Approved Use

Symptomatic relief of cough.
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
333 ng/mL
60 mg single, oral
dose: 60 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
BENPROPERINE, (S)- plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
153 ng/mL
60 mg single, oral
dose: 60 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
BENPROPERINE, (R)- plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
146.4 ng/mL
80 mg single, oral
dose: 80 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
BENPROPERINE plasma
Homo sapiens
population: UNKNOWN
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
4257 ng × h/mL
60 mg single, oral
dose: 60 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
BENPROPERINE, (S)- plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
2010 ng × h/mL
60 mg single, oral
dose: 60 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
BENPROPERINE, (R)- plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
5234.31 ng × h/mL
80 mg single, oral
dose: 80 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
BENPROPERINE plasma
Homo sapiens
population: UNKNOWN
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
17 h
60 mg single, oral
dose: 60 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
BENPROPERINE, (S)- plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
14 h
60 mg single, oral
dose: 60 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
BENPROPERINE, (R)- plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
24.7 h
80 mg single, oral
dose: 80 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
BENPROPERINE plasma
Homo sapiens
population: UNKNOWN
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
Doses

Doses

DosePopulationAdverse events​
80 mg single, oral
Highest studied dose
healthy, ADULT
Health Status: healthy
Age Group: ADULT
Sex: M
Food Status: UNKNOWN
Sources:
PubMed

PubMed

TitleDatePubMed
Resonance light scattering study on the interaction of benproperine phosphate with eriochrome blue black R in the presence of sodium dodecylbenzene sulphonate and its analytical application.
2008-09-19
[Nondestructive quantitative analysis of Cofrel medicines by improved partial least squares-NIR spectroscopy].
2007-06
Identification and quantitative determination of benproperine metabolites in human plasma and urine by liquid chromatography-tandem mass spectrometry.
2006-01-02
Identification of some benproperine metabolites in humans and investigation of their antitussive effect.
2005-12
Anti-tussive activity of benproperine enantiomers on citric-acid-induced cough in conscious guinea-pigs.
2004-02
Patents

Patents

Sample Use Guides

1 or 2 tablets 3 times daily, according to severity of cough. Tablets should be swallowed whole and not chewed.
Route of Administration: Oral
In Vitro Use Guide
10(-5) g/ml of Benproperine (ASA 158/5) caused remarkable reduction of the contraction of the tracheal muscle preparation of a guinea pig caused by histamine HCl.
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:18:52 GMT 2025
Edited
by admin
on Mon Mar 31 18:18:52 GMT 2025
Record UNII
3AA6IZ48YK
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BENPROPERINE
INN   MART.   MI   WHO-DD  
INN  
Official Name English
COFREL
Preferred Name English
Benproperine [WHO-DD]
Common Name English
ASA 158/5 FREE BASE
Code English
ASA-158/5 FREE BASE
Code English
benproperine [INN]
Common Name English
1-(2-(2-BENZYLPHENOXY)-1-METHYLETHYL)PIPERIDINE
Systematic Name English
BENPROPERINE [MI]
Common Name English
BENPROPERINE [MART.]
Common Name English
Classification Tree Code System Code
WHO-VATC QR05DB02
Created by admin on Mon Mar 31 18:18:52 GMT 2025 , Edited by admin on Mon Mar 31 18:18:52 GMT 2025
NCI_THESAURUS C66917
Created by admin on Mon Mar 31 18:18:52 GMT 2025 , Edited by admin on Mon Mar 31 18:18:52 GMT 2025
WHO-ATC R05DB02
Created by admin on Mon Mar 31 18:18:52 GMT 2025 , Edited by admin on Mon Mar 31 18:18:52 GMT 2025
Code System Code Type Description
DRUG BANK
DB13309
Created by admin on Mon Mar 31 18:18:52 GMT 2025 , Edited by admin on Mon Mar 31 18:18:52 GMT 2025
PRIMARY
DRUG CENTRAL
5236
Created by admin on Mon Mar 31 18:18:52 GMT 2025 , Edited by admin on Mon Mar 31 18:18:52 GMT 2025
PRIMARY
MESH
C477447
Created by admin on Mon Mar 31 18:18:52 GMT 2025 , Edited by admin on Mon Mar 31 18:18:52 GMT 2025
PRIMARY
CHEBI
37560
Created by admin on Mon Mar 31 18:18:52 GMT 2025 , Edited by admin on Mon Mar 31 18:18:52 GMT 2025
PRIMARY
CAS
2156-27-6
Created by admin on Mon Mar 31 18:18:52 GMT 2025 , Edited by admin on Mon Mar 31 18:18:52 GMT 2025
PRIMARY
PUBCHEM
2326
Created by admin on Mon Mar 31 18:18:52 GMT 2025 , Edited by admin on Mon Mar 31 18:18:52 GMT 2025
PRIMARY
WIKIPEDIA
BENPROPERINE
Created by admin on Mon Mar 31 18:18:52 GMT 2025 , Edited by admin on Mon Mar 31 18:18:52 GMT 2025
PRIMARY
MERCK INDEX
m2321
Created by admin on Mon Mar 31 18:18:52 GMT 2025 , Edited by admin on Mon Mar 31 18:18:52 GMT 2025
PRIMARY Merck Index
NCI_THESAURUS
C78103
Created by admin on Mon Mar 31 18:18:52 GMT 2025 , Edited by admin on Mon Mar 31 18:18:52 GMT 2025
PRIMARY
EPA CompTox
DTXSID10862853
Created by admin on Mon Mar 31 18:18:52 GMT 2025 , Edited by admin on Mon Mar 31 18:18:52 GMT 2025
PRIMARY
INN
3118
Created by admin on Mon Mar 31 18:18:52 GMT 2025 , Edited by admin on Mon Mar 31 18:18:52 GMT 2025
PRIMARY
EVMPD
SUB05728MIG
Created by admin on Mon Mar 31 18:18:52 GMT 2025 , Edited by admin on Mon Mar 31 18:18:52 GMT 2025
PRIMARY
SMS_ID
100000086375
Created by admin on Mon Mar 31 18:18:52 GMT 2025 , Edited by admin on Mon Mar 31 18:18:52 GMT 2025
PRIMARY
RXCUI
236749
Created by admin on Mon Mar 31 18:18:52 GMT 2025 , Edited by admin on Mon Mar 31 18:18:52 GMT 2025
PRIMARY RxNorm
ChEMBL
CHEMBL2105910
Created by admin on Mon Mar 31 18:18:52 GMT 2025 , Edited by admin on Mon Mar 31 18:18:52 GMT 2025
PRIMARY
FDA UNII
3AA6IZ48YK
Created by admin on Mon Mar 31 18:18:52 GMT 2025 , Edited by admin on Mon Mar 31 18:18:52 GMT 2025
PRIMARY
Related Record Type Details
ENANTIOMER -> RACEMATE
SALT/SOLVATE -> PARENT
ENANTIOMER -> RACEMATE
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY